TP53 and endometrial cancer: This ProMisE classification distinguishes endometrial cancer with (1) mismatch repair deficiency (MMRd), (2) DNA polymerase epsilon (POLE) mutation, (3) wild-type p53 (p53wt), and (4) abnormal p53 (p53abn) [171].